French Sanofi Gives Up mRNA COVID-19 Vaccine Development Over Saturated Market

PARIS (Sputnik) - French pharmaceutical Sanofi halts the development of its mRNA COVID-19 vaccine without launching the third trial phase as the market is expected to be saturated by the end of the year, Executive Vice President Thomas Triomphe told France Press Agency on Tuesday.